Annual Revenue Growth (Last Twelve Months): questdiagnostics.com (DGX)

Quest Diagnostics management's disciplined approach is successfully implementing molecular diagnostics, as confirmed by the current chart on GURU.Markets: the trailing 12-month sales growth relative to the previous year is currently holding at 9.20. The company is expanding its influence through the acquisition of local networks in a bid for dominance. The business relies on a national duopoly, where the key success factor remains the competition for lucrative insurance contracts.
Quest Diagnostics Inc. (DGX) - metric breakdowns and financial figures

This indicator measures the relative change in aggregate revenue over the last twelve months, neutralizing quarterly volatility to capture real-time demand. By analyzing the year-over-year (TTM) operating revenue trend, an investor can see the impact of the aging US population and the expansion of genomic testing on the scaling of the Quest Diagnostics (DGX) business, which allows for an assessment of the company's market position stability.